INPLASY202670032

Updated Evidence for Sucroferric Oxyhydroxide in Dialysis Patients: Meta-Analysis of Dual Metabolic Benefits and Population-Specific Efficacy Differences

Keywords: sucroferric oxyhydroxide; hyperphosphatemia; dialysis; end-stage renal disease; iron metabolism; renal anemia; meta-analysis.

Read and download full-text here - PDF 202670032

Review Status: completed but not published